Taylor Zhang Joins LCGC’s Editorial Advisory Board
LCGC Magazine is pleased to announce the addition of Taylor Zhang to its editorial advisory board.
Zhang is a principal scientist and group leader in protein analytical chemistry at Genentech in South San Francisco, where he has worked since 2006. Prior to his work with Genentech, Zhang was a research specialist and senior analytical biochemist at Dow Chemical. He has more than ten years of experience in bioprocess development and has authored more than 20 publications in the field of bioanalytical chemistry.
Zhang’s research interests involve using different separation techniques for therapeutic protein characterization, and developing methods for the quality control system. He and his group are responsible for analytical characterization, method development, and technical transfers for clinical and commercial products, and for evaluation and implementation of new analytical techniques into these clinical and commercial control systems of therapeutic protein drugs.
He received his PhD in analytical chemistry in 2000 from Iowa State University (Ames, Iowa), where his research focused on separation methods, primarily high throughput capillary electrophoresis coupled with on-line sample preparation.
Presenting GC Data Comparisons to Laypersons to Understand Potential Courtroom Implications
January 6th 2025In forensic science, scientific testimony is routinely presented in court to juries who may have limited or no scientific background, putting law enforcement and defense personnel in the position of having to make rapid decisions in short timeframes based on findings of which they are not specialists. Katelynn Perrault Uptmor, Assistant Professor of Chemistry at William & Mary (Williamsburg, Virginia) believes that the introduction of new technologies into the framework of routine forensic analysis must therefore bridge the gap between introduction of new and novel analytical science and the communication of that science to a court of law, and that analytical chemistry research must be mindful of the need to fill this gap in promoting new technologies.
Detailed Glycosylation Analysis of Therapeutic Enzymes Utilizing Comprehensive 2D-LC–MS
January 3rd 2025In this article, the use of comprehensive two-dimensional liquid chromatography (LC×LC) coupled to mass spectrometry (MS) for characterizing glycosylation of therapeutic enzymes is presented.
Advancing Gene Therapy: Enzyme Selection for Effective RNA Oligonucleotide Mapping
New gene therapy modalities, such as CRISPR guide RNA (single guide ribonucleic acid [sgRNA]) and messenger RNA (mRNA), continue to make progress in both primate and first-in-human trials. As this progress builds, the industry remains accountable for characterizing these molecules to meet the requirements of regulatory authorities.
